Breast Cancer Clinical Trial

Study of Bimatoprost Gel on Eyelash Growth

Summary

A internally controlled, single-blinded, randomized controlled trial to investigate the use of Bimatoprost eyelash gel on eyelash growth and appearance in breast cancer patients who suffer from madarosis (loss of eyelashes) due to the side effects of chemotherapy. IND and IRB approval have been obtained.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

18-80 YO females
madarosis or hypotrichosis (loss of eyelashes) due to chemotherapy used to treat breast cancer
only breast cancer patients

Exclusion Criteria:

inability to follow up, apply gel
active eye/eyelid infection or inflammatory process
cancer not related to breast cancer, healthy patients
males

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

20

Study ID:

NCT01200251

Recruitment Status:

Completed

Sponsor:

Duke University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Duke University Medical Center
Durham North Carolina, 27710, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

20

Study ID:

NCT01200251

Recruitment Status:

Completed

Sponsor:


Duke University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider